Amplia Therapeutics Limited
$0.080000
2
-$0.00-0% Thursday 13:30
Statistics
Day High
0.08
Day Low
0.08
52W High
0.24
52W Low
0.039
Volume
19,200
Avg. Volume
-
Mkt Cap
41.05M
P/E Ratio
-
Dividend Yield
-
Dividend
-
Upcoming
Earnings
29MayExpected
Expected EPS
N/A
Actual EPS
N/A
Financials
-Profit Margin
Unprofitable0Revenue
-7.64MNet Income
People Also Follow
This list is based on the watchlists of people on Stock Events who follow INNMF. It's not an investment recommendation.
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
Array Technologies
ARRY
Mkt Cap1.2B
TG Therapeutics
TGTX
Mkt Cap7.58B
Puma Biotechnology
PBYI
Mkt Cap373.09M
Kura Oncology
KURA
Mkt Cap803.41M
Incyte
INCY
Mkt Cap21.68B
About
Established in 2000 and headquartered in Melbourne, Australia, Amplia Therapeutics Limited is a pharmaceutical firm dedicated to the discovery and development of focal adhesion kinase (FAK) inhibitors. The company's therapeutic endeavors are concentrated on oncology (cancer) and chronic fibrotic diseases. Its drug development pipeline includes AMP945, a FAK inhibitor that has successfully completed Phase I clinical trials and is being explored for its efficacy in treating pancreatic cancer, idiopathic pulmonary fibrosis, and a broader spectrum of cancerous and fibrotic conditions. Another compound, AMP886, is also under development for potential applications in cancer and fibrotic disorders. Amplia Therapeutics maintains a strategic collaboration with the Garvan Institute of Medical Research in Sydney, and the company adopted its current name in September 2018, having previously operated as Innate Immunotherapeutics Limited.
Show more...
CEO
Dr. Christopher J. Burns B.Sc., BSc(Hons), Ph.D.
Employees
1
Country
Australia
ISIN
AU0000023822
Listings
0 Comments
Share your thoughts
FAQ
What is Amplia Therapeutics Limited stock price today?▼
The current price of INNMF is $0.08 USD — it has decreased by -0% in the past 24 hours. Watch Amplia Therapeutics Limited stock price performance more closely on the chart.
What is Amplia Therapeutics Limited stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Amplia Therapeutics Limited stocks are traded under the ticker INNMF.
Is Amplia Therapeutics Limited stock price growing?▼
INNMF stock has fallen by -2.44% compared to the previous week, the month change is a -29.2% fall, over the last year Amplia Therapeutics Limited has showed a +105.13% increase.
What is Amplia Therapeutics Limited market cap?▼
Today Amplia Therapeutics Limited has the market capitalization of 41.05M
When is the next Amplia Therapeutics Limited earnings date?▼
Amplia Therapeutics Limited is going to release the next earnings report on November 27, 2026.
What is Amplia Therapeutics Limited revenue for the last year?▼
Amplia Therapeutics Limited revenue for the last year amounts to 0 USD.
What is Amplia Therapeutics Limited net income for the last year?▼
INNMF net income for the last year is -7.64M USD.
How many employees does Amplia Therapeutics Limited have?▼
As of June 19, 2026, the company has 1 employees.
In which sector is Amplia Therapeutics Limited located?▼
Amplia Therapeutics Limited operates in the Health & Wellness sector.
When did Amplia Therapeutics Limited complete a stock split?▼
The last stock split for Amplia Therapeutics Limited was on May 03, 2018 with a ratio of 1:10.
Where is Amplia Therapeutics Limited headquartered?▼
Amplia Therapeutics Limited is headquartered in Melbourne, Australia.